This year marks Hines’s fifth consecutive season dedicating his cleats to MDA’s cause. He continues to champion the mission through his public service announcement for MDA and fundraising initiatives, ...
Novartis may have signed off on the second-largest pharma acquisition of 2025 so far, but as the company’s CEO sees it—it’s never about the price tag. | Novartis may have signed off on the second ...
A neuromuscular medicine expert and leader in the field of amyotrophic lateral sclerosis (ALS), Jinsy A. Andrews, MD, joins NYU Langone Health's Department of Neurology to lead its ALS Center, which ...
Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, presented Phase 1 data for its lead candidate, MF-300, at the ...
By adding a microRNA molecule to ALS models, Tel Aviv University, Ben-Gurion University and Weizmann Institute researchers ...
NewcelX ( ($NCEL) ) has shared an announcement. On November 17, 2025, NewcelX Ltd. announced the appointment of Prof. Jeremy Shefner, MD, PhD, to ...
In his role on the SAB of NewcelX, Prof. Shefner will provide strategic guidance on the Company's programs in ALS, including ...
Biogen on Monday said the positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the high-dose regimen of Spinraza for the treatment of 5q SMA, ...
Positive CHMP opinion is based on data from the DEVOTE study which evaluated the high dose regimen of nusinersen in treatment-naive participants ...
The article 🌱 Patch AM: Dallas families struggle to find care for neuromuscular diseases appeared first on Dallas Patch. Hi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback